Yoseph Shaaltiel, Executive VP, R&D at Protalix BioTherapeutics, Inc. (PLX), sold 30,000 shares at $3.85 ($109K) on 2009-05-14, disclosed to the SEC on 2009-05-20.
Open-market sale of $109k PLX by Executive VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.51 | 20,000 | $70K | 64.6% |
| 2 | $3.85 | 10,000 | $39K | 35.4% |
| Total | $3.62 avg | 30,000 | $109K | 100% |
| Filing → |
| PLX | SELL | 2010-06-23 | $371K | — | Filing → |
| PLX | SELL | 2010-05-03 | $89K | — | Filing → |
| PLX | SELL | 2010-04-16 | $9K | — | Filing → |